Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 506 entries
View as:

Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00358657 Org: User:
Start: 05/24/06 End: 05/25/19 Due: 05/25/20

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Phase: N/A Priority: Normal
NCT ID: NCT04431479 Org: User:
Start: 06/29/20 End: 08/02/26 Due: 08/02/27

Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00119340 Org: User:
Start: 04/30/05 End: 11/30/07 Due: 11/30/08

HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women

Phase: N/A Priority: Normal
NCT ID: NCT01815580 Org: User:
Start: 07/31/13 End: 06/30/21 Due: 06/30/22

Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00317876 Org: User:
Start: 06/30/98 End: - Due: -

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00049504 Org: User:
Start: 01/31/02 End: 02/28/14 Due: 02/28/15

Biological Therapy in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00045357 Org: User:
Start: 11/30/01 End: 08/31/08 Due: 08/31/09

Red and Processed Meat Effects on the Metabolome and Microbiome

Phase: N/A Priority: Normal
NCT ID: NCT05274906 Org: User:
Start: 11/16/21 End: 02/07/23 Due: 02/07/24

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00093743 Org: User:
Start: 01/31/00 End: - Due: -

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT04198922 Org: User:
Start: 12/11/20 End: 04/30/27 Due: 04/30/28

MsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01418209 Org: User:
Start: 11/30/11 End: 01/31/13 Due: 01/31/14

Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00622895 Org: User:
Start: 09/01/06 End: 08/01/17 Due: 08/01/18

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00027924 Org: User:
Start: 10/31/01 End: 05/31/03 Due: 05/31/04

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01804101 Org: User:
Start: 05/07/13 End: 01/10/17 Due: 01/10/18

Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00112567 Org: User:
Start: 04/30/03 End: 07/31/07 Due: 07/31/08

Partnership for a Hispanic Diabetes Prevention Program

Phase: N/A Priority: Normal
NCT ID: NCT01564797 Org: User:
Start: 07/31/08 End: 12/31/11 Due: 12/31/12

Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00919503 Org: User:
Start: 07/31/09 End: 06/10/20 Due: 06/10/21

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Phase: N/A Priority: Normal
NCT ID: NCT06922188 Org: User:
Start: 03/31/25 End: 12/18/29 Due: 12/18/30

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003145 Org: User:
Start: 08/31/97 End: - Due: -

Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00009711 Org: User:
Start: 03/31/96 End: 08/31/05 Due: 08/31/06

FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06609928 Org: User:
Start: 02/24/25 End: 10/01/42 Due: 10/01/43

Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04809766 Org: User:
Start: 12/14/21 End: 01/15/25 Due: 01/15/26

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01231412 Org: User:
Start: 11/30/10 End: 06/30/17 Due: 06/30/18

Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00016458 Org: User:
Start: 06/30/00 End: - Due: -

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00096161 Org: User:
Start: 05/31/03 End: 08/31/15 Due: 08/31/16